Science Share Discussion Threads

[battlebus2] 02/4/2015 10:04

Should continue up to around the 160p.

[battlebus2] 01/4/2015 15:19

Moving well now, buy backs always help..

[battlebus2] 01/4/2015 09:07

Another 210k shares bought back for treasury.

[battlebus2] 31/3/2015 08:19

Looks like another 155 at 141 this morning..

[battlebus2] 31/3/2015 07:22

Another 65k bought back :))

[battlebus2] 30/3/2015 14:51

Getting ready for new recent highs after the last few weeks of consolidation. Stock drying up...

[battlebus2] 30/3/2015 09:23

Continuing higher this morning, once the share buy back programme begins after the AGM we should be trading closer to 160 imv...

[battlebus2] 27/3/2015 09:52

Good to see a tick up, the new license deal just shows the value of SAG and why we should be trading higher than todays price.

[battlebus2] 27/3/2015 08:31

Thanks Hastings , i hadn't noticed that contract news. Very good news indeed.

[hastings] 26/3/2015 18:20

hxxp://www.cambridge-news.co.uk/Sagentia-TT-Electronics-agree-new-licence/story-26237946-detail/story.html

[battlebus2] 24/3/2015 22:09

Sorry to see these dip a little, soon it'll be top up time.

[anumidium] 15/3/2015 20:11

@battlebus: the market rate is dictated by supply and demand. By tailoring supply to meet demand the price is suppressed.

[oregano] 06/3/2015 16:27

I have never heard of a company controlling supply of shares in this way. I don't quite know what to make of it. Good that MR wants to retain the listing and access to capital markets, but clear that PI's are of no interest to him. In reality that is also sensible, as we don't supply much capital and create noise. I guess if they manage to buy shares in at 113p as they did recently and sell shares at 140p SAG are generating value for existing shareholders. So all in probably a good thing.

[battlebus2] 05/3/2015 19:50

They will pay market price at the time.

[anumidium] 05/3/2015 19:04

Good H2. 3% yield is not bad. Was hoping for a special as well though.

Not a big fan of the plan to trade our shares in order to satisfy institutional supply/demand. I guess that is the outcome of the consultation around the tender offer but institutions should have to receive/pay the market rate like we do.

Expect to return to growth next year with the Oakland acquisition + the lower GBP/USD.

[battlebus2] 04/3/2015 13:55

Numis has just reiterated it's buy stance on SAG with a raised price target of 177 from 150..

[wjccghcc] 04/3/2015 12:25

There wasn't last year either.

[oregano] 04/3/2015 10:24

Strange there is no outlook statement.

[battlebus2] 04/3/2015 09:05

Westhouse this morning reiterates it's add stance with a target of 175p..

[battlebus2] 04/3/2015 08:08

Still a clear under valuation imv.. I also believe it's likely we will see a new institutional investor.

[battlebus2] 04/3/2015 07:56

Results out. As expected with the difficult currency headwinds.

Second half back to growth.

Cash balances worth 86p

4P dividend and a buy back of up to 10% of the shares in issue, this may be used to facilitate an institutional investor to gain a holding due to lack of liquidity at present

Still on the look out for acquisitions.


Summary

In summary, 2014 had a more challenging start than the prior year which, as previously reported, had been exceptionally strong. This was made more difficult by a rapidly deteriorating foreign exchange environment in the first half. However the second half of the year saw a return to organic growth in the core consultancy business, despite the negative currency impact. Through tight cost control, operating margins were above the Board's target and a satisfactory overall result for the year was achieved.

The integration of OTM Consulting, acquired in mid-2013, has been successful and the integration of Oakland is now in progress. The Board continues to evaluate corporate opportunities to accelerate the growth of Sagentia, although there can be no certainty that any transaction(s) will occur.

In the absence of a major acquisition, the Board has considered how best to deliver value for Shareholders and is proposing specific measures, namely a very attractive dividend, increased share buy-back programme and supply side liquidity. Shareholders will have the opportunity to vote on these proposals at the Annual General Meeting, scheduled for 21 May 2015.

[battlebus2] 03/3/2015 17:01

Good luck for tomorrow holders..

[battlebus2] 28/2/2015 14:10

[...][...]

Sagentia gets a mention here but i dont think the author has grasped the full story here.
SAG. EY 11%
Sagentia (SAG) may be the riskiest company in the list because of its relatively short record of profitability. The research and development consultancy has transformed itself from a jam tomorrow company to a jam today one by switching to a contractual model. It earns most profit in North America and Sagentia has indicated profit in 2014 will be lower than profit in 2013 because of the strong pound. It remains highly profitable though, and a braodening base of clients from across the healthcare, consumer goods and oil and gas industries, augers well.

[atholl91] 27/2/2015 15:45

Anum: Agree. Have never understood the reluctance to tender way above the market price if you think your stock is undervalued. Having run a fairly large public company and sat on the board of a big investment trust I've never heard a convincing argument against it.